Columnist Teri Sforza writes that childhood obesity in California is on the rise, state data shows. Free school meals have ...

The case for GLP-1 drugs like Ozempic possibly causing blindness is building. A new paper out this week describes several ...

A new study adds to a growing body of research suggesting a potential link between popular GLP-1 medications like Ozempic and vision loss.

A new study published JAMA Ophthalmology has brought attention to a series of vision problems observed in patients taking ...

Now, one type of weight-loss medication is proving helpful with another health issue. In a study published Feb. 12 in JAMA ...

A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide — known by the brand name ...

For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don't just curb their desire to eat; for some, they also lead them to drink ...

Novo Nordisk’s blockbuster GLP-1 diabetes drug Ozempic led to improvements in some measures of alcohol use disorder in a ...

Some brand name GLP-1s include Ozempic and Trulicity — though Winfrey ... It works by mimicking the hormone GLP-1, which the body releases after eating, helping people feel full and slowing ...

Semaglutide is the active ingredient in diabetes drug Ozempic and obesity medication Wegovy (since Wegovy was approved in 2021, Ozempic has become a common off-label treatment for obesity).

THESE DRUGS COULD POSSIBLY PREVENT HEART ATTACK AND STROKE. THE RESULTS ARE PROMISING FOR HEART PATIENTS.. THESE MEDICATIONS ARE MOSTLY KNOWN FOR TREATING DIABETES AND OBESITY.. BUT THE F-D-A HAS ...